Claire Fraser - 04 Jan 2023 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
Director
Signature
/s/ Thomas J. DesRosier, Attorney-in-fact for Claire Fraser
Issuer symbol
MCRB
Transactions as of
04 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 15:35:42 UTC
Previous filing
10 Feb 2022
Next filing
26 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (right to buy) Award $0 +48,000 $0.000000 48,000 04 Jan 2023 Common Stock 48,000 $5.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in four equal installments on each anniversary of January 4, 2023 or in full immediately prior to the occurrence of a change in control.